US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (286)
  • Diseases & Conditions (3812)
  • Drug Delivery (293)
  • Therapeutic Area (7263)
  • Vaccines (727)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Standard Chem. & Pharm. Co., Ltd. : Ingredients - Company Profile, SWOT & Financial Report
4/20/2014 | published by: Canadean Ltd
... depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, key employees, company locations and ...  |  read more...
$125.00
Zhejiang Hangzhou Xinfu Pharmaceutical Co.,Ltd. : Ingredients - Company Profile, SWOT & Financial Report
4/20/2014 | published by: Canadean Ltd
... and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, key employees, company locations and subsidiaries as ...  |  read more...
$125.00
Chattem, Inc.: Consumer Packaged Goods - Company Profile & SWOT Report
4/18/2014 | published by: Canadean Ltd
... its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, recent developments as well as company locations and subsidiaries. Summary This report is a crucial ...  |  read more...
$125.00
Chengzhi Co., Ltd : Ingredients - Company Profile, SWOT & Financial Report
4/18/2014 | published by: Canadean Ltd
... company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, recent developments, key employees, company locations and subsidiaries as well as ...  |  read more...
$125.00
GlaxoSmithkline Consumer Healthcare Ltd. : Consumer Packaged Goods - Company Profile, SWOT & Financial Report
4/18/2014 | published by: Canadean Ltd
... depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, key competitors, financial analysis, mergers & acquisitions, ...  |  read more...
$125.00
Sector Report Specialty Pharmaceuticals Industry
4/16/2014 | published by: Bourne Capital Partners, L.L.C.
... continue to increase. Industry growth is anticipated to continue as is merger and acquisition volume. Bourne Partners Specialty Pharmaceuticals Industry Sector Report offers unique insight into industry trends and trading and transaction comparables from across ...  |  read more...
$495.00
EUSA Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' EUSA Pharma, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Applied Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Applied Biosystems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Dainippon Sumitomo Pharma Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Dainippon Sumitomo Pharma Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
$350.00
CytRx Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' CytRx Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Depomed, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Depomed, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Oragenics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Oragenics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
ViroPharma Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' ViroPharma Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Eli Lilly and Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
$350.00
Sun Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Sun Pharmaceutical Industries Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
$350.00
Sangamo BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Sangamo BioSciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
BioWa, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' BioWa, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Organon BioSciences N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Organon BioSciences N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Chiesi Farmaceutici S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Chiesi Farmaceutici S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Ranbaxy Laboratories Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Ranbaxy Laboratories Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Gedeon Richter Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Gedeon Richter Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Affitech A/S (formerly Pharmexa A/S) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Affitech A/S (formerly Pharmexa A/S) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
$350.00
Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Salix Pharmaceuticals, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Abbott Laboratories - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Abbott Laboratories Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
Barr Laboratories, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Barr Laboratories, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
< prev 1    3  4  5  6  7  8  9  10  
 
Our Clients